PSA (PSORIATIC ARTHRITIS)
Clinical trials for PSA (PSORIATIC ARTHRITIS) explained in plain language.
Never miss a new study
Get alerted when new PSA (PSORIATIC ARTHRITIS) trials appear
Sign up with your email to follow new studies for PSA (PSORIATIC ARTHRITIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for psoriatic arthritis relief
Disease control Recruiting nowThis study is testing whether an experimental medication called D-2570 can help control symptoms of active psoriatic arthritis. Researchers will enroll 222 adults with the condition to compare different doses of the drug against a placebo over 12 weeks. The main goal is to see if…
Matched conditions: PSA (PSORIATIC ARTHRITIS)
Phase: PHASE2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug trial offers hope for Tough-to-Treat arthritis
Disease control Recruiting nowThis study is testing an investigational drug called SPY002-072 to see if it can reduce disease activity in adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis. It will compare the drug to a placebo in about 285 particip…
Matched conditions: PSA (PSORIATIC ARTHRITIS)
Phase: PHASE2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC